Results 221 to 230 of about 44,802 (314)
Multimodal Management of Refractory Ventricular Tachycardia Due to Aconitine Poisoning: A Case Report in a Resource-Limited Setting. [PDF]
Sitthiprawiat P +2 more
europepmc +1 more source
ABSTRACT Nacubactam is a β‐lactamase inhibitor. Early‐phase studies with 1000/2000/4000/8000 mg nacubactam monotherapy were not powered to assess proarrhythmic risk. Therefore, this analysis pooled electrocardiogram data from two placebo‐controlled studies to quantify potential effects of nacubactam on cardiac repolarization.
Jun Morita, Sue McKendrick, Yuji Kumagai
wiley +1 more source
Intracardiac adenosine triphosphate for cardioversion of supraventricular tachycardia in a hydropic foetus: a case report. [PDF]
Liu J, Luo G, Sun Y, Xu Y, Pan S.
europepmc +1 more source
ABSTRACT QT interval prolongation associated with drug administration is an important consideration in drug development. Patients with COVID‐19 are at increased risk for cardiac complications, and QT interval prolongation correlates with higher mortality.
Chi‐Chi Peng +6 more
wiley +1 more source
Community pharmacies in early detection of obstructive sleep apnea: findings from a nationwide survey. [PDF]
Giombi F +16 more
europepmc +1 more source
Antiarrhythmics, Inotropes, and Vasopressors
Bethany R. Tellor, Keki R. Balsara
core +1 more source
Advances in Electrocardiogram‐Based Non‐Invasive Blood Glucose Monitoring Technology
ABSTRACT Blood glucose monitoring is fundamental to diabetes management, yet traditional invasive methods are limited by patient discomfort and infection risks. In recent years, electrocardiogram (ECG), a conventional tool for cardiovascular assessment, has gained attention as a prospective method for non‐invasive blood glucose monitoring.
Qi Zeng +5 more
wiley +1 more source
Atrial overdrive pacing in drug-refractory postinfarction electrical storm case report. [PDF]
Xu XY +7 more
europepmc +1 more source

